Concepedia

Abdelghani Jebahi

AJ

3

Publications

118

Citations

3

H-Index

2013

Active since

Affiliations

Université de Caen Normandie(Current)

Centre François Baclesse

Normandie Université

Abdelghani Jebahi is an author at Université de Caen Normandie specializing in tumor biology, cell death, and ovarian cancer.

Top concepts

MedicineCell DeathCell BiologyTumor BiologyCancer BiologyOvarian CancerOncologyApoptosisImmunologyPharmacology

Publications per year

2013–2016

3

Publications

3

PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced

Abdelghani Jebahi, Marie Villedieu, Cécile Pétigny-Lechartier et al. · Cancer Letters · 2014 · 53 citations · Full text

Medicine, Pi3k/mtor Dual Inhibitor, Immunology +12

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737

Cécile Pétigny-Lechartier, Charlène Duboc, Abdelghani Jebahi et al. · Molecular Cancer Therapeutics · 2016 · 45 citations

Oncology, Chemoprevention Strategy, Medicine +15

18F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer

Stéphanie Lheureux, Charlotte Lecerf, Mélanie Briand et al. · Translational Oncology · 2013 · 20 citations · Full text

Rows per page

1–3 of 3